Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
AKM SOLIFENACIN, PHARMACOR SOLIFENACIN (Pharmacor Pty Ltd)
Product name
AKM SOLIFENACIN, PHARMACOR SOLIFENACIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
161 working days (255)
Active ingredients
Solifenacin succinate
Registration type
New generic medicine
Indication
AKM SOLIFENACIN, PHARMACOR SOLIFENACIN (tablets) is indicated for the treatment of overactive bladder with symptons of urge urinary incontinence, urgency or increased urinary frequency.